Liyu He

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Diabetic Nephropathy

Induced Apoptosis

Top Venues

Pharmaceuticals (Basel, Switzerland)

Laboratory investigation; a journal of technical methods and pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Hao Li, Wenni Dai, Li Xiao, Lin Sun, Liyu He
Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery. Pharmaceutics 15 (8) (2023)
Muyao Ye, Ming Yang, Wenni Dai, Hao Li, Xun Zhou, Yinyin Chen, Liyu He
Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Hao Li, Wenni Dai, Zhiwen Liu, Liyu He
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Hao Li, Wenni Dai, Zhiwen Liu, Liyu He
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Hao Li, Wenni Dai, Zhiwen Liu, Liyu He
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Hao Li, Wenni Dai, Zhiwen Liu, Liyu He
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Zhiwen Liu, Hong Liu, Li Xiao, Guoyong Liu, Lin Sun, Liyu He
STC-1 ameliorates renal injury in diabetic nephropathy by inhibiting the expression of BNIP3 through the AMPK/SIRT3 pathway. Laboratory investigation; a journal of technical methods and pathology 99 (5) (2019)